Latest Moderna News & Updates
See the latest news and media coverage for Moderna. We track all announcements, press releases, and industry mentions in real time, all in one place.
mRNA therapeutics and vaccine developer
modernatx.com- Headquarters
- Cambridge, United States
- Founded year
- 2010
- Company type
- Public company
- Number of employees
- 1,000–6,500
Last updated
Latest news about Moderna
In short: Moderna received EU approval for the world’s first dual flu-COVID vaccine and reported strong Q1 2026 sales driven by international growth.
Company announcements
-
Moderna announces Phase 3 results publication for mRNA-1010 influenza vaccine
The New England Journal of Medicine publishes safety and efficacy data from study P304 in adults aged 50+.
-
Moderna updates on discontinued CF collaboration with Vertex
Vertex terminates Phase 1/2 study of VX-522 due to tolerability issues. No broader portfolio impact; learnings inform future efforts.
-
Moderna reports Q1 2026 earnings
Executive team discusses financial performance and late-stage pipeline milestones in IR Insights video. Plans include 10% revenue growth and expense reductions.
-
Moderna announces first Phase 3 dosing for mRNA-1018
Participants in the U.S. and UK have been dosed. CEPI invests up to $54.3 million to advance the H5 influenza vaccine to licensure.
Media coverage
-
Moderna’s mRNA flu vaccine outperforms standard shot, study finds
Moderna’s new mRNA based seasonal flu vaccine is more effective than traditional flu shots at preventing flu, a late stage international study has shown.1 Researchers...
-
First Dual Flu-COVID Vaccine, mCombriax, Wins EU Approval
The European Commission granted marketing authorization for mCombriax (messenger RNA [mRNA]-1083), a...
-
Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues
After pausing a trial for a Moderna-partnered cystic fibrosis candidate due to subpar tolerability, Vertex Pharmaceuticals has now decided to discontinue the program entirely. ...
-
Moderna to ask U.S., European regulators to OK emergency use of COVID-19 vaccine
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the...
Track Moderna and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Moderna competitors & trending companies
Browse news for competitors to Moderna and other trending companies.
Orna Therapeutics
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove